Intellectual Property Magazine
EPO’s CRISPR hearing: day two
Dr Emma Longland, HGF
The European Patent Office’s (EPO) Board of Appeal is currently undertaking oral hearings in a long-running patent dispute
involving the Broad Institute, over the revocation of one of its CRISPR patents.